BioCentury
ARTICLE | Distillery Therapeutics

Endocrine / Metabolic

May 3, 2017 6:11 PM UTC

Cell culture and mouse experiments identified oxyindole-based inhibitors of PGC-1α gluconeogenic activity that could help treat Type II diabetes. High throughput screening of a small molecule library ...